Evidence map›Paper›PMID 42061984›Full record

ArticleLife science alliance2026

Alveolar macrophage subtypes express cholesterol and inflammation genes in cystic fibrosis.

Xin Li, Fred W Kolling, Daniel Aridgides, Lorraine Gwilt, Diane Mellinger, Claudia V Jakubzick, Alix Ashare

Abstract read
In one paragraph

Article in Life science alliance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xin LiDepartment of Microbiology and Immunology, Dartmouth Geisel School of Medicine, Hanover, NH, USA.ORCID 0000-0002-2050-2628
Fred W KollingDepartment of Biomedical Data Science, Dartmouth Geisel School of Medicine, Hanover, NH, USA.ORCID 0000-0002-6178-9901
Daniel AridgidesDepartment of Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH, USA.
Lorraine GwiltDepartment of Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH, USA.
Diane MellingerDepartment of Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH, USA.
Claudia V JakubzickDepartment of Microbiology and Immunology, Dartmouth Geisel School of Medicine, Hanover, NH, USA.ORCID 0000-0002-3731-0198
Alix AshareDepartment of Microbiology and Immunology, Dartmouth Geisel School of Medicine, Hanover, NH, USA alix.ashare@hitchcock.org.ORCID 0000-0002-2413-5845

Funding

Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Fred W Kolling IV · 1985 to 2026
$91.3M
Zhao - Proj 2P20GM130454 · NIGMS · DARTMOUTH COLLEGE · PI Shannon Soucy · 2019 to 2026
$27.2M
Pilot and Feasibility ProgramP30DK117467 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI Raouf S. Amin · 2018 to 2026
$11.4M
Human and mouse transcriptome profiling identifies cross-species homology of mononuclear phagocytesR35HL155458 · NHLBI · DARTMOUTH COLLEGE · PI Claudia V Jakubzick · 2021 to 2026
$5.9M
Mechanisms of Impaired Inflammation Resolution in Cystic Fibrosis Lung DiseaseR01HL174700 · NHLBI · DARTMOUTH-HITCHCOCK CLINIC · PI ALIX ASHARE · 2024 to 2026
$1.8M
The Role of Macrophage Metabolic Crosstalk in CF Chronic Lung InflammationR56HL158923 · NHLBI · DARTMOUTH-HITCHCOCK CLINIC · PI ASHARE, ALIX · 2023 to 2023
$637k
Macrophage Pathogen Interactions in Regional Cystic Fibrosis Lung InflammationK24HL150453 · NHLBI · DARTMOUTH-HITCHCOCK CLINIC · PI ASHARE, ALIX · 2020 to 2024
$542k
Acquisition of the NextSeq2000 Sequencing platform to Increase Next Generation Sequencing Throughput While Reducing Costs at DartmouthS10OD030242 · OD · DARTMOUTH COLLEGE · PI KOLLING IV, FRED W · 2021 to 2021
$321k
10X Genomics Chromium Single-cell Sequencing to Expand Research At DartmouthS10OD025235 · OD · DARTMOUTH COLLEGE · PI TOMLINSON, CRAIG R · 2018 to 2018
$125k
NCI NIH HHS P30 CA023108NHLBI NIH HHS K24 HL150453NHLBI NIH HHS R01 HL174700NHLBI NIH HHS R35 HL155458NHLBI NIH HHS R56 HL158923NIDDK NIH HHS P30 DK117467NIGMS NIH HHS P20 GM130454NIH HHS S10 OD025235NIH HHS S10 OD030242
6 · The paper itself

Abstract

Cystic fibrosis (CF) is a genetic disease that causes lung inflammation. Although new treatments have improved the quality of life of people with CF, inflammation remains a problem. Alveolar macrophages have been shown to be important mediators of CF lung inflammation although the interactions between macrophages and other immune cells in CF are poorly understood. To identify and compare the cellular composition between CF and healthy airspace macrophages and monocytes, healthy control and CF subjects underwent bronchoscopy and single-cell RNA sequencing was performed on the BAL fluid. Unbiased clustering identified 12 macrophage subtypes. We found up-regulation of macrophages expressing CDKN1A and LDLR, both of which are known to alter cholesterol metabolism and promote inflammation. Pathway analysis revealed important interactions between macrophages and monocytes in CF that likely contribute to overall inflammation and adaptation of recruited monocytes to the CF lung. Some of the top pathways identified were related to inflammation and lipid metabolism, which may contribute to persistent inflammation in CF. Our results may identify novel potential therapeutic targets to treat CF lung inflammation.

Indexed as

CholesterolCystic FibrosisInflammationMacrophages, AlveolarAdultBronchoalveolar Lavage FluidFemaleHumansLipid MetabolismLungMaleMonocytesCholesterol

Identifiers

PMID42061984
PMCPMC13139742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.